| European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint … PYK Van den Bergh, RDM Hadden, P Bouche, ... european journal of neurology 17 (3), 356-363, 2010 | 1713* | 2010 |
| Electrophysiological classification of Guillain‐Barré syndrome: clinical associations and outcome RDM Hadden, DR Cornblath, RAC Hughes, J Zielasek, HP Hartung, ... Annals of neurology 44 (5), 780-788, 1998 | 1080 | 1998 |
| Pathogenesis of Guillain–Barré syndrome RAC Hughes, RDM Hadden, NA Gregson, KJ Smith Journal of neuroimmunology 100 (1-2), 74-97, 1999 | 553 | 1999 |
| European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task … PYK Van den Bergh, PA van Doorn, RDM Hadden, B Avau, ... Journal of the Peripheral Nervous System 26 (3), 242-268, 2021 | 529 | 2021 |
| Preceding infections, immune factors, and outcome in Guillain–Barré syndrome RDM Hadden, H Karch, HP Hartung, J Zielasek, B Weissbrich, J Schubert, ... Neurology 56 (6), 758-765, 2001 | 486 | 2001 |
| Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome S Keddie, J Pakpoor, C Mousele, M Pipis, PM Machado, M Foster, ... Brain 144 (2), 682-693, 2021 | 334 | 2021 |
| Peripheral Nerve Society Guideline* on the classification, diagnosis, investigation, and immunosuppressive therapy of non‐systemic vasculitic neuropathy: executive summary MP Collins, PJB Dyck, GS Gronseth, L Guillevin, RDM Hadden, D Heuss, ... Journal of the Peripheral Nervous System 15 (3), 176-184, 2010 | 262 | 2010 |
| Cognitive behavioural therapy for adults with dissociative seizures (CODES): a pragmatic, multicentre, randomised controlled trial LH Goldstein, EJ Robinson, JDC Mellers, J Stone, A Carson, M Reuber, ... The Lancet Psychiatry 7 (6), 491-505, 2020 | 248 | 2020 |
| Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind, randomised … IN van Schaik, F Eftimov, PA van Doorn, E Brusse, LH van den Berg, ... The Lancet Neurology 9 (3), 245-253, 2010 | 239 | 2010 |
| Randomized trial of interferon β-1a in chronic inflammatory demyelinating polyradiculoneuropathy RDM Hadden, B Sharrack, S Bensa, SE Soudain, RAC Hughes Neurology 53 (1), 57-57, 1999 | 185 | 1999 |
| European Federation of neurological Societies/Peripheral nerve Society Guideline* on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint … Joint Task Force of the Efns and the Pns Journal of the Peripheral Nervous System 10 (3), 220-228, 2005 | 163 | 2005 |
| The nonsystemic vasculitic neuropathies MP Collins, RD Hadden Nature Reviews Neurology 13 (5), 302-316, 2017 | 148 | 2017 |
| Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain‐Barré syndrome AY Doets, RAC Hughes, R Brassington, RDM Hadden, J Pritchard Cochrane Database of Systematic Reviews, 2020 | 136 | 2020 |
| Long-term remission of CIDP after pulsed dexamethasone or short-term prednisolone treatment F Eftimov, M Vermeulen, PA Van Doorn, E Brusse, IN Van Schaik, ... Neurology 78 (14), 1079-1084, 2012 | 134 | 2012 |
| Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials R Suppiah, RDM Hadden, R Batra, NK Arden, MP Collins, L Guillevin, ... Rheumatology 50 (12), 2214-2222, 2011 | 131 | 2011 |
| International Guillain‐Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in … BC Jacobs, B van den Berg, C Verboon, G Chavada, DR Cornblath, ... Journal of the Peripheral Nervous System 22 (2), 68-76, 2017 | 126 | 2017 |
| Vasculitis as an adverse event following immunization–systematic literature review C Bonetto, F Trotta, P Felicetti, GS Alarcón, C Santuccio, NS Bachtiar, ... Vaccine 34 (51), 6641-6651, 2016 | 120 | 2016 |
| Guillain–barre syndrome E Malek, J Salameh Seminars in neurology 39 (05), 589-595, 2019 | 114 | 2019 |
| Plasma exchange/sandoglobulin Guillain-Barré syndrome trial group. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome RD Hadden, DR Cornblath, RA Hughes, J Zielasek, HP Hartung, ... Ann Neurol 44 (5), 780-788, 1998 | 114 | 1998 |
| Changing outcome in inflammatory neuropathies: Rasch–comparative responsiveness THP Draak, EK Vanhoutte, SI Van Nes, KC Gorson, WL Van der Pol, ... Neurology 83 (23), 2124-2132, 2014 | 100 | 2014 |
